Procter & Gamble Company (PG)

Procter & Gamble Company is a consumer staples company listed on the NYSE as common stock under the symbol PG. Through its branded portfolio, the company sells consumer packaged goods worldwide across five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. Its brands include Head & Shoulders, Herbal Essences, Pantene, Rejoice, Native, Old Spice, Safeguard, Secret, Olay, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Metamucil, Neurobion, Pepto-Bismol, Vicks, Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer, Luvs, Pampers, Always, Always Discreet, Tampax, Bounty, Charmin, and Puffs. The company distributes products through a broad range of channels, including mass merchandisers, e-commerce, grocery and specialty beauty retailers, club stores, drug and department stores, wholesalers, distributors, pharmacies, duty-free outlets, professional channels, and direct-to-consumer sales. Founded in 1837, Procter & Gamble is headquartered in Cincinnati, Ohio.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-PG
$162.07
9.7% Upside
Fair
$163.61
10.8% Upside
Fair
Good
July 24, 2026
August 17, 2026
4.354
2.9%
July 29, 2026
21.1x
6.4x
4.0x
347.3 B
369.5 B
9.6%
99.8%
8.0
61.2%
92.1%
Valuation • Fair Value

Procter & Gamble Company (NYSE-PG) Fair Value by Valuation Model

Compare the primary fair value estimate for Procter & Gamble Company (NYSE-PG) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$162.07

Estimated upside of 9.7% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$167.80

Discounted cash flow valuation reference.

Ben Graham Formula Value

$77.78

Classic Ben Graham valuation formula reference.

DDM Fair Value

$199.48

Dividend discount model valuation reference.

EPV Fair Value

$108.32

Earnings power value estimate.

Comps Fair Value

$152.84

Comparable-company valuation reference.

Analyst Price Target

$163.61

Analysts imply upside of 10.8%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Procter & Gamble Company (NYSE-PG) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Procter & Gamble Company (NYSE-PG)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

86.717 B

Current operating scale indicator.

Revenue Forecast

87.055 B

Forward revenue estimate.

EBITDA

25.042 B

Current operating profitability reference.

EBITDA Forecast

23.703 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Procter & Gamble Company (NYSE-PG) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Procter & Gamble Company (NYSE-PG)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.59

No elevated caution signal from this screen.

Altman Z-Score

8.0

Relatively strong balance-sheet zone.

FCF / Net Income

92.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Procter & Gamble Company (NYSE-PG). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Procter & Gamble Company (NYSE-PG)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 29, 2026

Days to Earnings

8

Dividend Payment Date

August 17, 2026

Ex-Dividend Date

July 24, 2026

Dividend Yield

2.9%

Income yield reference.

Upcoming Dividend

4.354

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

61.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Procter & Gamble Company (NYSE-PG), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Procter & Gamble Company (NYSE-PG) Stock Forecast & Technical Outlook

Review Procter & Gamble Company (NYSE-PG) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Procter & Gamble Company (NYSE-PG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Procter & Gamble Company (NYSE-PG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Procter & Gamble Company (NYSE-PG) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Procter & Gamble Company (NYSE-PG) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Procter & Gamble Company (NYSE-PG) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Procter & Gamble Company (NYSE-PG)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Procter & Gamble Company (NYSE-PG) has a Hold consensus, with 9 buy, 10 hold and 0 sell recommendations in the current data set.

Buy 9
Hold 10
Sell 0
FAQ Fast Investor Answers

Procter & Gamble Company (NYSE-PG) Stock FAQ

Quick answers about Procter & Gamble Company (NYSE-PG) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$162.07
Estimated upside 9.7%
Valuation Rating
Undervalued
Estimated upside of 9.7%
Analyst Target
$163.61
Implied upside 10.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for Procter & Gamble Company (NYSE-PG) is $162.07. This implies an estimated upside of 9.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 9.7% versus the current market price.

The available analyst price target for Procter & Gamble Company (NYSE-PG) is $163.61. The analyst target implies estimated upside of 10.8%.

The current financial health read for Procter & Gamble Company (NYSE-PG) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Procter & Gamble Company (NYSE-PG) is July 29, 2026.

Based on the current data, dividend yield is 2.9%, upcoming dividend amount is 4.354, ex-dividend date is July 24, 2026, payment date is August 17, 2026.

The current P/E ratio listed for Procter & Gamble Company (NYSE-PG) is 21.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Procter & Gamble Company is 347.3 B.

The current enterprise value listed for Procter & Gamble Company is 369.5 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Procter & Gamble Company is NYSE-PG, and the stock is listed on NYSE.

Procter & Gamble Company (NYSE-PG) is listed on NYSE.

The current debt-to-total-capital ratio listed for Procter & Gamble Company is 9.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Procter & Gamble Company is 99.8%. Free float helps investors understand how much of the share base is available for public trading.